For yet another year, Myeloma Patients Europe will be present at the European Society for Medical Oncology Congress. The event will take place in Madrid between the 26 to 30 of September. The main congress of European Oncology is expected to meet over 16.000 attendees from over 120 countries. ESMO 2014 intends to merge state-of-the-art oncology with the latest breakthrough discoveries, from cost-effective anti-cancer treatments to best supportive care.
MPE will be represented by several delegates at the 18th EHA congress in Stockholm (13-16 June 2013). We also have a booth where printed versions of our key documents and recent publications will be provided, such as the MPE report on Myeloma Patient Perspectives, the executive summary of the report, a summary of our strategic plan 2013-2018 and the Clinical Trial Charter developed by MPE.
As part of the European Bone Marrow Transplant (EBMT) group’s annual conference, there will be a Patient and Family Day on Saturday 6 April 2013. The EBMT Annual Meeting is the most important annual event for research and education in the field of bone marrow transplantation in Europe and during the conference a special Patient and Family Day will be held for patients who have undergone a bone marrow transplant and their families.
The 54th Annual Meeting of the American Society of Haematology (ASH) took place on the 8 – 12 December inAtlanta,USA. This year, some 200 talks and over 500 posters dedicated to myeloma research were presented. Here, we summarise some of the highlights emerging from the conference: